Cell type-specific anti-cancer properties of valproic acid: independent effects on HDAC activity and Erk1/2 phosphorylation
about
Improved therapeutic effect on malignant glioma with adenoviral suicide gene therapy combined with temozolomide.Pyrroloquinoline Quinone Induces Cancer Cell Apoptosis via Mitochondrial-Dependent Pathway and Down-Regulating Cellular Bcl-2 Protein ExpressionNew perspectives of valproic acid in clinical practice.Nitric oxide and histone deacetylases modulate cocaine-induced mu-opioid receptor levels in PC12 cells.Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of SnailValproic acid protects against haemorrhagic shock-induced signalling changes via PPARγ activation in an in vitro modelValproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results.Valproic acid overcomes transforming growth factor-β-mediated sorafenib resistance in hepatocellular carcinoma.Sodium valproate potentiates staurosporine-induced apoptosis in neuroblastoma cells via Akt/survivin independently of HDAC inhibition.The teratogenic potencies of valproic acid derivatives and their effects on biological end-points are related to changes in histone deacetylase and Erk1/2 activities.Enantioselective apoptosis induction in histiocytic lymphoma cells and acute promyelocytic leukemia cells.
P2860
Q33410559-38DE1D30-04B4-430A-BF30-9129D02AD40EQ34084843-C1F96B54-0CE7-46BD-A487-2DFE09E23198Q34380256-38BA3956-7291-4DAD-BEDC-DA97FF6B361CQ34451436-EAB7F5BD-8A95-4309-9F67-928CD9D25262Q37114711-7AB9C400-77F2-4753-9846-25B98BBA57D8Q37441534-F4EE27EF-8E2D-4B80-A528-0BDF7A841434Q38016227-5D4322CE-2852-43C9-ABFD-3D3E3A0C0693Q38996046-CD8FC105-D22C-4CDF-898C-0116B5AEB6E1Q39253762-5F2266AD-A637-4651-89B6-5BB650CD3CE4Q39570462-6D011A1E-A7CD-4D13-AEF9-DBA50B9D1DCFQ44152775-77F72953-A438-4700-81C6-1C95972E661E
P2860
Cell type-specific anti-cancer properties of valproic acid: independent effects on HDAC activity and Erk1/2 phosphorylation
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cell type-specific anti-cancer ...... ity and Erk1/2 phosphorylation
@ast
Cell type-specific anti-cancer ...... ity and Erk1/2 phosphorylation
@en
type
label
Cell type-specific anti-cancer ...... ity and Erk1/2 phosphorylation
@ast
Cell type-specific anti-cancer ...... ity and Erk1/2 phosphorylation
@en
prefLabel
Cell type-specific anti-cancer ...... ity and Erk1/2 phosphorylation
@ast
Cell type-specific anti-cancer ...... ity and Erk1/2 phosphorylation
@en
P2093
P2860
P356
P1433
P1476
Cell type-specific anti-cancer ...... ity and Erk1/2 phosphorylation
@en
P2093
Elisabeth Bock
Eugene A Lepekhin
Galina Skladchikova
Vladimir Berezin
P2860
P2888
P356
10.1186/1471-2407-10-383
P407
P577
2010-07-21T00:00:00Z
P5875
P6179
1042939374